MOLN — Molecular Partners AG Balance Sheet
0.000.00%
Last trade - 00:00
- $160.09m
- -$23.50m
- CH₣7.04m
- 35
- 21
- 62
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 95.1 | 174 | 133 | 249 | 187 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.55 | 2.84 | 25.7 | 1.7 | 3.08 |
Prepaid Expenses | |||||
Total Current Assets | 99.9 | 178 | 164 | 255 | 192 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.24 | 9.39 | 8.15 | 7.24 | 5.68 |
Net Intangible Assets | |||||
Total Assets | 105 | 188 | 173 | 262 | 198 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28.6 | 57.7 | 46.9 | 17.3 | 14.4 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 50.8 | 80.3 | 65.4 | 27.1 | 21.9 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 54.1 | 107 | 107 | 235 | 176 |
Total Liabilities & Shareholders' Equity | 105 | 188 | 173 | 262 | 198 |
Total Common Shares Outstanding |